Literature DB >> 27605742

Association of Elevated Serum Lipoprotein(a), Inflammation, Oxidative Stress and Chronic Kidney Disease with Hypertension in Non-diabetes Hypertensive Patients.

Surapon Tangvarasittichai1, Patcharin Pingmuanglaew2, Orathai Tangvarasittichai1.   

Abstract

Hypertension is the most common cardiovascular risk factor. Lipoprotein(a) [Lp(a)], inflammation, oxidative stress and chronic kidney disease (CKD) exacerbate the response to tissue injury and acts as markers of the vascular disease, especially in glomerulosclerosis. We compared the clinical characteristics of 138 non-diabetes hypertensive women (ndHT) patients with 417 non-diabetes normotensive subjects and tested the association of hypertension with Lp(a), inflammation, CKD and oxidative stress by using multiple logistic regression. BP, BMI, waist circumference, creatinine, Lp(a), inflammation and malondialdehyde levels were significantly higher and CKD state in the ndHT patients (p < 0.05). Multiple logistic regression showed hypertension associated with increased Lp(a), inflammation, ORs and 95 % CIs were 2.52 (1.33, 4.80), 2.75 (1.44, 5.27) after adjusting for their covariates. Elevated serum Lp(a) and inflammation levels concomitants with increased oxidative stress and CKD were the major risk factors associated with hypertension and implications for the increased risk of HT and vascular disease.

Entities:  

Keywords:  Chronic kidney disease; Hypertension; Lipoprotein(a); Malondialdehyde; hs-CRP

Year:  2016        PMID: 27605742      PMCID: PMC4992491          DOI: 10.1007/s12291-016-0553-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  31 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  The role of systemic hypertension in the progression of nondiabetic renal disease.

Authors:  C Marcantoni; T H Jafar; L Oldrizzi; A S Levey; G Maschio
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

4.  Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response.

Authors:  G Lippi; V Braga; S Adami; G Guidi
Journal:  Clin Chim Acta       Date:  1998-03-09       Impact factor: 3.786

5.  A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis.

Authors:  K W Walton; J Hitchens; H N Magnani; M Khan
Journal:  Atherosclerosis       Date:  1974 Sep-Oct       Impact factor: 5.162

6.  Mitochondria control functional CaV1.2 expression in smooth muscle cells of cerebral arteries.

Authors:  Damodaran Narayanan; Qi Xi; Lawrence M Pfeffer; Jonathan H Jaggar
Journal:  Circ Res       Date:  2010-07-08       Impact factor: 17.367

7.  Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.

Authors:  L A Sechi; L Zingaro; C Catena; A Perin; S De Marchi; E Bartoli
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

8.  Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian Patients.

Authors:  Baidarbhi Chakraborty; Gaurav Vishnoi; Binita Goswami; Srinivas H Gowda; Debashish Chowdhury; Sarita Agarwal
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-14       Impact factor: 2.136

9.  Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1.

Authors:  Ho-Keun Kwon; Ji-Sun Hwang; Jae-Seon So; Choong-Gu Lee; Anupama Sahoo; Jae-Ha Ryu; Won Kyung Jeon; Byoung Seob Ko; Sung Haeng Lee; Zee Yong Park; Sin-Hyeog Im
Journal:  BMC Cancer       Date:  2010-07-24       Impact factor: 4.430

10.  Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

Authors:  W Terres; E Tatsis; B Pfalzer; F U Beil; U Beisiegel; C W Hamm
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.